Zydus gets nod to conduct Phase II clinical study in patients with CAPS in Australia
New Delhi, Dec 13: Drug firm Zydus Cadila on Monday said it has received approval to commence Phase II clinical study of its upcoming product with patients suffering with Cryopyrin-Associated Periodic Syndrome (CAPS) in Australia.…
